Amatsigroup buys Q Biologicals in 'fragmented' EU bio-services space
French CDMO Amatsigroup will offer complete biologics development services and expand its European presence through the acquisition of Q Biologicals.
French CDMO Amatsigroup will offer complete biologics development services and expand its European presence through the acquisition of Q Biologicals.
Recipharm has raised SEK276m ($32m) to part finance the acquisition of a majority stake in Indian CMO Nitin Life Sciences that it announced in October.
Austrianova has launched cell banking and fill finish services for cell therapy developers at its facility in Singapore.
CROs have been experiencing increased pressure to implement risk-based monitoring (RBM), and while adoption has been slow, it is gaining speed, say speakers at CROWN Congress.
Drug-loaded dental implants which release payload on-demand could alleviate invasive procedures associated with chronic diseases, scientists suggest.
The recent tide of Warning Letters issued to Chinese API and finished formulation makers reflects an increase in regulatory oversight, the US FDA says.